Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? A systematic review (2017)
Attributed to:
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.semarthrit.2017.01.009
PubMed Identifier: 28325471
Publication URI: http://europepmc.org/abstract/MED/28325471
Type: Journal Article/Review
Parent Publication: Seminars in Arthritis and Rheumatism
Issue: 1
ISSN: 0049-0172